HOME >> BIOLOGY >> NEWS
Taking the next step toward growing our own fuel

URBANA -- Developing a petroleum-free fuel from corn byproducts is one of the goals of a newly named research theme at the University of Illinois at Urbana-Champaign. Eight research laboratories will pool their expertise, attacking the problems from different directions to improve the efficiency of bioconversion of plant fibers into fuels and other value added products.

The new theme is the seventh to be chosen for the Institute for Genomic Biology under the direction of Harris A. Lewin, Gutgsell Endowed Chair in the department of animal sciences. Although the building housing the IGB will not be completed until 2006, the work that will go on inside already has begun.

Lewin said that the new IGB research theme, led by Hans Blaschek, will address one of the most critical problems facing our nation.

"With crude oil at $50 per barrel, we must examine renewal sources of energy as a viable alternative to fossil fuels," Lewin said. "The vision and experience of Blaschek and his co-workers will be important in setting the national agenda for future research on renewable energy sources. Importantly, the outcomes of this research may have direct benefit to farmers and the agricultural industries of the Midwest. I am proud to have the new theme on Molecular Bioengineering of Biomass Conversion as part of the IGB's research, education and economic development portfolio."

Blaschek is a microbiologist in the College of Agricultural, Consumer and Environmental Sciences. He has been studying microorganisms that are used in fermentation processes for over 20 years. He is striving to overcome the obstacles related to biomass conversion into value-added products.

"The beneficiaries of this research will be agriculture and agriculture-based industries in Illinois," Blaschek said, "but ultimately all of us will benefit as consumers of energy." He believes that renewable fuel made from corn is the direction we need to go in order
'"/>

Contact: Debra Levey Larson
dlarson@uiuc.edu
217-244-2880
University of Illinois at Urbana-Champaign
7-Oct-2004


Page: 1 2

Related biology news :

1. Taking a supplement of glycine helps prevent degenerative diseases such as arthrosis or osteoporosis
2. Taking heart failure to the MAT1
3. Taking chips to the next level of gene hunting
4. Vax and Pax: Taking turns to build an eye
5. Taking evolutions temperature: Researchers pinpoint the energy it takes to make a species
6. Taking a bite out of a fellow worker helps wasps recruit new foragers
7. Taking a break from fractures: A closer look at vitamin D
8. Taking a flying jump
9. Taking the piste out of Alpine vegetation
10. Bursts of waves drive immune system soldiers toward invaders
11. A decisive step toward a cure for insulin dependent diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Taking the next step toward growing our own fuel

(Date:7/23/2014)... Tracking of blue whales by satellite over a 15-year ... whales consistently return to feed in specific locations each ... in the open-access journal PLOS ONE by ... data may be used to mitigate human threats to ... has been slow to recover since the establishment of ...
(Date:7/23/2014)... cultured from cystic fibrosis patients, scientists at the UNC ... have shown that a new CF drug counteracts the ... The finding, published today in the journal Science ... becomes unstable and loses its ability to function properly ... research offers several insights into how novel CF pharmacotherapies ...
(Date:7/23/2014)... , , , , , ... , , , , , ... that changing how medical care is delivered could help prevent multiple chronic diseases and extend healthy lifespan. The idea, they argue, would be to target the... ... , , , , ... , , , , , ...
Breaking Biology News(10 mins):Blue whales' dangerous feeding grounds 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 4Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5
(Date:7/23/2014)... /PRNewswire-iReach/ -- Think Drinks are a neuroscience-backed drink regimen ... They are the first functional focus beverage to give ... alternative to the temporary fix associated with energy drinks. ... 29, 2014, with hopes to raise $50,000 over the ... http://photos.prnewswire.com/prnh/20140723/129697 Think Drinks were ...
(Date:7/23/2014)... 23 de julio de 2014 ADB ... Compañía) ha anunciado hoy una asociación con Austen ... (ABIA o el Instituto), para el propósito de ... de terapia de señal bioeléctrica (el E-QURE BST ... Instituto, que tiene una importante experiencia en cicatrización ...
(Date:7/23/2014)... , July 23, 2014 regulated information -- UCB ... and development pipeline with positive topline results from ... . This study was designed to evaluate the efficacy ... 200 mg/day, without titration) compared to placebo, as ... partial-onset seizures, not fully controlled despite treatment with ...
(Date:7/23/2014)... 23, 2014 With the ability to record ... for more than 15 minutes, Fastec Imaging has brought the ... high speed imaging. “Finally, a high speed camera that can ... in our everyday lives.” proclaims Matt Kearney, VP of Sales ... been to demystify and simplify the traditionally complicated workflow of ...
Breaking Biology Technology:truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3
Cached News: